Brooks Laboratories Limited BROOKS.BO Stock
106.95 INR
{{ price }}
0.668297%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
India
Exchange
BSE
Market Cap
2.81B INR
LOW - HIGH [24H]
104.12
-
106.95 INR
VOLUME [24H]
2.75K INR
{{ volume }}
P/E Ratio
0
Earnings per share
-9.51 INR
Brooks Laboratories Limited Price Chart
Brooks Laboratories Limited BROOKS.BO Financial and Trading Overview
| Brooks Laboratories Limited stock price | 106.95 INR |
| Previous Close | 64.77 INR |
| Open | 63.5 INR |
| Bid | 66.95 INR x 0 |
| Ask | 67.3 INR x 0 |
| Day's Range | 63.5 - 67.5 INR |
| 52 Week Range | 57.05 - 141.8 INR |
| Volume | 9.85K INR |
| Avg. Volume | 9.71K INR |
| Market Cap | 1.66B INR |
| Beta (5Y Monthly) | 1.375 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -9.51 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 53 INR |
BROOKS.BO Valuation Measures
| Enterprise Value | 1.43B INR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.6303442 |
| Price/Book (mrq) | 1.9269866 |
| Enterprise Value/Revenue | 2.256 |
| Enterprise Value/EBITDA | -5.397 |
Trading Information
Brooks Laboratories Limited Stock Price History
| Beta (5Y Monthly) | 1.375 |
| 52-Week Change | -23.93% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 141.8 INR |
| 52 Week Low | 57.05 INR |
| 50-Day Moving Average | 63.71 INR |
| 200-Day Moving Average | 95.81 INR |
BROOKS.BO Share Statistics
| Avg. Volume (3 month) | 9.71K INR |
| Avg. Daily Volume (10-Days) | 7.69K INR |
| Shares Outstanding | 24.7M |
| Float | 5.99M |
| Short Ratio | N/A |
| % Held by Insiders | 69.02% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -33.067% |
| Operating Margin (ttm) | -52.91% |
| Gross Margin | 19.93% |
| EBITDA Margin | -41.79% |
Management Effectiveness
| Return on Assets (ttm) | -13.68% |
| Return on Equity (ttm) | -29.82% |
Income Statement
| Revenue (ttm) | 632.05M INR |
| Revenue Per Share (ttm) | 38.01 INR |
| Quarterly Revenue Growth (yoy) | -55.70% |
| Gross Profit (ttm) | 128.06M INR |
| EBITDA | -264183008 INR |
| Net Income Avi to Common (ttm) | -209002000 INR |
| Diluted EPS (ttm) | -12.98 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.75M INR |
| Total Cash Per Share (mrq) | 0.51 INR |
| Total Debt (mrq) | 65.12M INR |
| Total Debt/Equity (mrq) | 8.81 INR |
| Current Ratio (mrq) | 0.836 |
| Book Value Per Share (mrq) | 34.925 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -144906000 INR |
| Levered Free Cash Flow (ttm) | 96.9M INR |
Profile of Brooks Laboratories Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | 201, The Summit Business Park |
| ZIP | 400093 |
| Phone | 91 22 6193 3100 |
| Website | https://www.brookslabs.net |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye/ear drops. The company was incorporated in 2002 and is based in Mumbai, India.
Q&A For Brooks Laboratories Limited Stock
What is a current BROOKS.BO stock price?
Brooks Laboratories Limited BROOKS.BO stock price today per share is 106.95 INR.
How to purchase Brooks Laboratories Limited stock?
You can buy BROOKS.BO shares on the BSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Brooks Laboratories Limited?
The stock symbol or ticker of Brooks Laboratories Limited is BROOKS.BO.
Which industry does the Brooks Laboratories Limited company belong to?
The Brooks Laboratories Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Brooks Laboratories Limited have in circulation?
The max supply of Brooks Laboratories Limited shares is 26.25M.
What is Brooks Laboratories Limited Price to Earnings Ratio (PE Ratio)?
Brooks Laboratories Limited PE Ratio is now.
What was Brooks Laboratories Limited earnings per share over the trailing 12 months (TTM)?
Brooks Laboratories Limited EPS is -9.51 INR over the trailing 12 months.
Which sector does the Brooks Laboratories Limited company belong to?
The Brooks Laboratories Limited sector is Healthcare.